10.38
price down icon2.81%   -0.30
after-market After Hours: 10.80 0.42 +4.05%
loading
Envveno Medical Corp stock is traded at $10.38, with a volume of 1,957. It is down -2.81% in the last 24 hours and down -1.42% over the past month. enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$10.68
Open:
$10.8
24h Volume:
1,957
Relative Volume:
0.12
Market Cap:
$6.80M
Revenue:
-
Net Income/Loss:
$-19.47M
P/E Ratio:
-0.4067
EPS:
-25.5243
Net Cash Flow:
$-15.57M
1W Performance:
-13.57%
1M Performance:
-1.42%
6M Performance:
-56.28%
1Y Performance:
-91.69%
1-Day Range:
Value
$10.38
$10.80
1-Week Range:
Value
$9.875
$12.02
52-Week Range:
Value
$8.67
$196.70

Envveno Medical Corp Stock (NVNO) Company Profile

Name
Name
Envveno Medical Corp
Name
Phone
949-261-2900
Name
Address
70 DOPPLER, IRVINE
Name
Employee
33
Name
Twitter
Name
Next Earnings Date
2026-05-06
Name
Latest SEC Filings
Name
NVNO's Discussions on Twitter

Compare NVNO vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
NVNO icon
NVNO
Envveno Medical Corp
10.38 7.00M 0 -19.47M -15.57M -25.52
ABT icon
ABT
Abbott Laboratories
87.17 152.48B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
295.25 111.40B 25.27B 3.34B 4.57B 8.6358
MDT icon
MDT
Medtronic Plc
77.79 100.53B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
55.98 84.50B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
82.91 48.04B 6.30B 1.07B 1.34B 1.8406

Envveno Medical Corp Stock (NVNO) Latest News

pulisher
May 01, 2026

enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve - MedTech Intelligence

May 01, 2026
pulisher
Apr 30, 2026

enVVeno Medical secures FDA IDE approval for venous valve study - Medical Device Network

Apr 30, 2026
pulisher
Apr 29, 2026

enVVeno Medical (NVNO) Secures FDA IDE Approval for Pivotal Stud - GuruFocus

Apr 29, 2026
pulisher
Apr 29, 2026

enVVeno Medical announces FDA awarded IDE approval to proceed with TAVVEB study - TipRanks

Apr 29, 2026
pulisher
Apr 29, 2026

enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve - BioSpace

Apr 29, 2026
pulisher
Apr 29, 2026

enVVeno Medical Wins FDA IDE for TAVVE Trial - TipRanks

Apr 29, 2026
pulisher
Apr 29, 2026

enVVeno receives FDA approval for venous valve pivotal trial By Investing.com - Investing.com South Africa

Apr 29, 2026
pulisher
Apr 29, 2026

enVVeno receives FDA approval for venous valve pivotal trial - Investing.com

Apr 29, 2026
pulisher
Apr 29, 2026

FDA clears enVVeno (NASDAQ: NVNO) pivotal enVVe CVI valve study - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

FDA allows first U.S. study of a nonsurgical vein valve for 3M patients - Stock Titan

Apr 29, 2026
pulisher
Apr 28, 2026

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Times Reporter

Apr 28, 2026
pulisher
Apr 27, 2026

NVNO enVVeno posts narrower than expected Q3 2025 loss, shares register small gains in today’s trading.CEO Statement - Newser

Apr 27, 2026
pulisher
Apr 20, 2026

enVVeno (NVNO) Stock Iron Condor (Breakdown Watch) 2026-04-20Community Sell Signals - Newser

Apr 20, 2026
pulisher
Apr 18, 2026

MSN Money - MSN

Apr 18, 2026
pulisher
Apr 13, 2026

What is enVVeno Medical Corporations market position2026 Price Swings & AI Driven Stock Movement Reports - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - The Florida Times-Union

Apr 11, 2026
pulisher
Apr 10, 2026

Stop Loss: What is enVVeno Medical Corporations market positionQuarterly Market Review & Technical Entry and Exit Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 08, 2026

Whats the profit margin of enVVeno Medical Corporation2026 Market Mood & Risk Managed Investment Signals - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 04, 2026

NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI

Apr 04, 2026
pulisher
Apr 01, 2026

enVVeno Medical Shares Crash After FDA Reaffirms VenoValve Rejection - MSN

Apr 01, 2026
pulisher
Mar 31, 2026

Dow Update: Is enVVeno Medical Corporation a strong candidate for buy and holdMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 31, 2026

Market Wrap: Whats the MACD signal for enVVeno Medical Corporation2026 Short Interest & Daily Profit Maximizing Tips - baoquankhu1.vn

Mar 31, 2026
pulisher
Mar 28, 2026

enVVeno Medical Corp (NVNO) SEC filings - GuruFocus

Mar 28, 2026
pulisher
Mar 28, 2026

enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus

Mar 28, 2026
pulisher
Mar 28, 2026

enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI

Mar 28, 2026
pulisher
Mar 27, 2026

Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn

Mar 27, 2026
pulisher
Mar 27, 2026

AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks

Mar 27, 2026
pulisher
Mar 27, 2026

EnVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of EnVVe(R) System - 富途牛牛

Mar 27, 2026
pulisher
Mar 27, 2026

No replacement vein valves are approved. enVVeno is pushing one toward a 2026 trial - Stock Titan

Mar 27, 2026
pulisher
Mar 26, 2026

[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView

Mar 26, 2026
pulisher
Mar 26, 2026

5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView

Mar 26, 2026
pulisher
Mar 21, 2026

If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan

Mar 21, 2026
pulisher
Mar 15, 2026

NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN

Mar 15, 2026
pulisher
Mar 13, 2026

Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus

Mar 13, 2026
pulisher
Mar 12, 2026

[144] enVVeno Medical Corp SEC Filing - Stock Titan

Mar 12, 2026
pulisher
Mar 11, 2026

Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 11, 2026
pulisher
Mar 09, 2026

enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 09, 2026
pulisher
Mar 04, 2026

NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times

Mar 04, 2026
pulisher
Mar 02, 2026

Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World

Mar 02, 2026

Envveno Medical Corp Stock (NVNO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$83.01
price up icon 0.41%
STE STE
$212.97
price up icon 0.34%
$59.48
price down icon 0.93%
PHG PHG
$26.45
price up icon 0.80%
$61.04
price up icon 0.07%
EW EW
$82.91
price down icon 0.50%
Cap:     |  Volume (24h):